Accès ouvert · CC BY

When stem cells meet COVID-19: recent advances, challenges and future perspectives

Article scientifique 2022 Sciences de la santé › Santé publique (OCDE 3.3) Anglais

Résumé

Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory coronavirus 2 is currently spreading throughout the world with a high rate of infection and mortality and poses a huge threat to global public health. COVID-19 primarily manifests as hypoxic respiratory failure and acute respiratory distress syndrome, which can lead to multiple organ failure. Despite advances in the supportive care approaches, there is still a lack of clinically effective therapies, and there is an urgent need to develop novel strategies to fight this disease. Currently, stem cell therapy and stem cell-derived organoid models have received extensive attention as a new treatment and research method for COVID-19. Here, we discuss how stem cells play a role in the battle against COVID-19 and present a systematic review and prospective of the study on stem cell treatment and organoid models of COVID-19, which provides a reference for the effective control of the COVID-19 pandemic worldwide.

Citer ce document

Li, S., Zhu, H., Zhao, M., Liu, W., Wang, L., Zhu, B., Xie, W., Zhao, C., Zhou, Y., Ren, C., Liu, H., & Jiang, X. (2022). When stem cells meet COVID-19: recent advances, challenges and future perspectives. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-021-02683-1

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 06/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 16

Téléchargements (hors robots) : 0

Méthode de comptage